Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

REMICADE®

Remicade (infliximab)

FDA INDICATION: Crohn’s disease, pediatric Crohn’s disease, ulcerative colitis, pediatric ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis. Prescribing Information

DISTRIBUTOR: Janssen Biotech

ROUTE OF ADMINISTRATION: Intravenous

FORM: Lyophilized

DOSAGE AND ADMINISTRATION:

Crohn’s disease: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some adult patients who initially respond to treatment may benefit from increasing the dose to 10 mg/kg if they later lose their response.

Pediatric Crohn’s disease: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

Ulcerative colitis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

Pediatric ulcerative colitis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

Rheumatoid arthritis: In conjunction with methotrexate, 3 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some patients may benefit from increasing the dose up to 10 mg/kg or treating as often as every 4 weeks.

Ankylosing spondylitis: 5 mg/kg at 0, 2 and 6 weeks, then every 6 weeks.

Psoriatic arthritis and plaque psoriasis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

HOW SUPPLIED: Each single dose vial contains 100 mg of infliximab for final reconstitution volume of 10 mL.

STORAGE REQUIREMENTS: Store unopened vials in a refrigerator at 2ºC to 8ºC (36ºF to 46ºF). Unopened vials may also be stored at temperatures up to a maximum for a single period of up to 6 months but not exceeding the original expiration date. Upon removal from refrigerated storage, vials cannot be returned to refrigerated storage.

OTHER WEBSITES: Care4Today.com, My Janssen CarePath